ArticleTargeted oncology2021

Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.

Sean Bujarski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.